PP83. MOLECULAR BIOLOGY ANALYSES ON MUSCULAR DYSTROPHIES
CRISTINA BORDEA (Matanie), Gisela Gaina, Aura Mihalcea, Marieta Costache, Elena Ionica University of Bucharest, Molecular Biology Centre, Romania e-mail: cribo_ro@yahoo.com, elena.i@unibuc.ro
*Corresponding Author:
page: 84

Abstract

The muscular dystrophies are a group of clinically and genetically heterogeneous myopathic disorders characterized by progressive degenerative change in skeletal muscle fibres. Several proteins from sarcolemma (dystrophin, sarcoglicans, caveolin-3), and muscle fibres cytoplasm (calpain 3) have been identified. Most of these proteins appear to play a role in supporting the structure of muscle fibres and some of them are known to be involved in molecular signalling and biochemical processes. Mutations in their genes are responsible for different forms of muscular dystrophies such as: i) Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD) which are X-linked allelic myopathies caused by dystrophin deficiency; ii) Limb Girdle Muscular Dystrophy type 2A (LGMD 2A) caused by mutations in the calpain 3 gene. Immunofluorescence and immunoblotting (western blotting) are the two methods used in our studies in order to evaluate the modifications of protein expression as a diagnostic tool. Dystrophin expression detected by immunofluorescence at the sarcolemma of normal skeletal muscle fibres is absent or severely reduced in DMD. Complete lack of this protein revealed by Western blot analyses confirms DMD diagnosis. In contrast, to BMD patients we can observe a reduced staining at the sarcolemma level and by Western blot we can observe a dystrophin of abnormal size or abundance. Concerning the study of calpain 3 protein, responsible for LGMD 2A, the only sensitive method capable to detect the expression's changes is Western blotting.




Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006